ESRX - Express Scripts Holding Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
77.56
+0.83 (+1.08%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close76.73
Open76.11
Bid77.00 x 200
Ask78.00 x 100
Day's Range75.92 - 77.81
52 Week Range55.80 - 85.07
Volume3,980,954
Avg. Volume3,263,622
Market Cap43.567B
Beta1.12
PE Ratio (TTM)9.69
EPS (TTM)8.01
Earnings DateAug 1, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2003-11-12
1y Target Est86.06
Trade prices are not sourced from all markets
  • Amazon PillPack
    Yahoo Finance Video18 days ago

    Amazon PillPack

    The Amazon PillPak deal is set but how soon will customers be able to get their prescriptions through the online giant? When Amazon bought Whole Foods shoppers were able to get the discounts the day the deal was done..

  • Analysts Expect Drug Supplier Whiplash To Endure on Rebate Changes
    Bloombergyesterday

    Analysts Expect Drug Supplier Whiplash To Endure on Rebate Changes

    Analysts agree Trump’s prescription drug plans look ugly -- but they are divided on the real financial impact of the changes on the pharmaceutical supply chain. While Jefferies expects the rebates debate to be an overhang, they only see a “modestly negative” impact in the worst case scenario, with Medicare beneficiaries and the federal government shouldering the bulk of the costs if rebates were eliminated. “The fundamental impact of an elimination of Medicare Part D rebates will likely be neutral to just modestly negative.” Removing drug rebates “may reduce competitive bidding advantage for CVS, ESRX, and UNH (Optum) in Part D.” Jefferies expects the sector to “trade sideways at best” for the near-term.

  • Can PBM Unit Boost Express Scripts' (ESRX) Q2 Earnings?
    Zacksyesterday

    Can PBM Unit Boost Express Scripts' (ESRX) Q2 Earnings?

    Strong performance by the PBM unit is likely to drive Express Scripts' (ESRX) top line in Q2. Home-delivery pharmacy care, specialty pharmacy care and drug data analysis services buoy optimism.

  • Trump's Drug-Price Push Butts Into Two Megadeals
    Bloomberg2 days ago

    Trump's Drug-Price Push Butts Into Two Megadeals

    Donald Trump’s drug-price push is steering right into health megadeals. The Trump administration’s budget office was sent a proposal by the Health and Human Services Department late Wednesday that seems to target pharmacy benefit managers — the middlemen in the pricing process — as part of efforts to change the way drugs are paid for.

  • MarketWatch2 days ago

    Shares of U.S. pharmacy middlemen drop on threat to rebates

    MARKET PULSE A policy being weighed by the Trump administration that could threaten drug price rebates, a widespread feature of the U.S. pharmaceutical system that largely benefits pharmaceutical middlemen, sent shares of those companies down in Thursday trade.

  • ACCESSWIRE3 days ago

    SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Express Scripts Holding Company - ESRX

    BALA CYNWYD, PA / ACCESSWIRE / July 18, 2018 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors Express Scripts Holding Company ("Express Scripts" or "the Company") (ESRX) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Cigna Corporation. Under the terms of the transaction, Express Scripts shareholders will receive only $48.75 in cash and 0.2434 of a share of the newly combined company for each share of Express Scripts stock they own.

  • Express Scripts subsidiary to add service center in St. Louis
    American City Business Journals3 days ago

    Express Scripts subsidiary to add service center in St. Louis

    A medical benefit management subsidiary of Express Scripts is set to add 100 jobs in the St. Louis area.

  • MarketWatch3 days ago

    Express Scripts unit eviCore to add 100 jobs in St. Louis

    MARKET PULSE Express Scripts Holding Co. (esrx) unit eviCore healthcare said Wednesday it's adding 100 jobs in St. Louis as it expands services to health care providers. The unit specialises in evidence-based medical benefit management services and is based in Bluffton, South Carolina.

  • PR Newswire3 days ago

    Express Scripts Subsidiary Expands Services to Healthcare Providers, Adding 100 Jobs in St. Louis

    eviCore Medical Benefit Management Opens New Provider Service Center ST. LOUIS and BLUFFTON, S.C. , July 18, 2018 /PRNewswire/ -- eviCore healthcare, a subsidiary of Express Scripts Holding Company (NASDAQ: ...

  • ACCESSWIRE4 days ago

    READ NOW: Monteverde & Associates PC Is Investigating The Acquisition Of Express Scripts Holding Company Scheduled For A Shareholder Vote On August 24, 2018 - ESRX

    NEW YORK, NY / ACCESSWIRE / July 17, 2018 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York ...

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit4 days ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    Express Scripts Holding Co NASDAQ/NGS:ESRX

  • ACCESSWIRE8 days ago

    Free Pre-Market Technical Recap on CVS Health and Three Additional Health Care Plans Stocks

    Stock Research Monitor: ESRX, AET, and ANTM LONDON, UK / ACCESSWIRE / July 13, 2018 / If you want a free Stock Review on CVS sign up now at www.wallstequities.com/registration . On Thursday, July 12, 2018, ...

  • PR Newswire9 days ago

    WeissLaw LLP Files Class Action Lawsuit Against Express Scripts Holding Company

    NEW YORK, July 12, 2018 /PRNewswire/ -- WeissLaw LLP announced that it has filed a class action on behalf of shareholders of Express Scripts Holding Company ("Express Scripts") (ESRX) seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act") in connection with the proposed acquisition of Express Scripts by Cigna Corporation ("Cigna").  The class action was commenced in the United States District Court for the Eastern District of Missouri, Eastern Division. On March 8, 2018, Express Scripts and Cigna issued a joint press release announcing that they had entered into a definitive agreement pursuant to which Cigna and Express Scripts will be combined under a new holding company, New Cigna, which will be renamed "Cigna Corporation" immediately after the merger ("Proposed Transaction").

  • CNBC9 days ago

    CVS, Aetna shares rise on report DoJ won't challenge their merger deal

    Shares of CVS Health and Aetna rose Thursday on a report the Department of Justice won't challenge their merger. Drugstore chain and pharmacy benefits manager CVS announced in December it would acquire health insurer Aetna for $69 billion in a deal that could reshape the health industry. Shares of CVS Health CVS and Aetna AET rose Thursday on a report the Department of Justice won't challenge their merger.

  • GlobeNewswire9 days ago

    Express Scripts Holding Company Announces Second Quarter 2018 Earnings Release Details

    Express Scripts Holding Company (ESRX) (“Express Scripts”) announced today its intention to release its 2018 second quarter financial results on Wednesday, August 1, 2018, after the market closes. Express Scripts is a healthcare opportunity company.

  • PR Newswire10 days ago

    Express Scripts Named a Best Place to Work for Disability Inclusion

    ST. LOUIS, July 11, 2018 /PRNewswire/ -- Express Scripts (ESRX) was again recognized with a 100 percent score on the Disability Equality Index® (DEI) for its ongoing commitment to being inclusive and welcoming to people of all abilities. The DEI is a national benchmarking tool and joint initiative of the American Association of People with Disabilities and the US Business Leadership Network®. "Express Scripts is proud of being a top-ranked company for disability inclusion for the second consecutive year," said Tim Wentworth, CEO and President of Express Scripts.

  • After Feuding With Drug Middlemen, Startup Fields a Competitor
    Bloomberg10 days ago

    After Feuding With Drug Middlemen, Startup Fields a Competitor

    Blink Health, a startup that helps patients shop for low-cost prescription drugs online, has helped set up a new pharmacy-benefit administration firm after big drugstore operators balked at filling orders placed through the service. Blink said on Wednesday that it had partnered with former officials of Express Scripts Holding Co. to create Blue Eagle Health, which it characterized as an alternative to large pharmacy-benefit managers who have been criticized by the Trump administration for their role in driving up drug costs. The venture “is replacing a complicated and opaque” pharmacy-payment system, said Geoffrey Chaiken, Blink’s chief executive officer.

  • Analyst: Express Scripts will grow alongside Amazon, even after purchase of PillPack
    American City Business Journals11 days ago

    Analyst: Express Scripts will grow alongside Amazon, even after purchase of PillPack

    "I think Amazon really isn’t so much taking aim at companies like Express Scripts, they’re really trying to take aim more at the traditional pharmacy market."

  • M&A Hits Record in 1H: Ride High With These ETFs
    Zacks12 days ago

    M&A Hits Record in 1H: Ride High With These ETFs

    Merger and acquisition activities across the globe hit record highs in the first half of 2018 driven by growing ambition of American companies.

  • OP company files antitrust suit against pharmacy giant
    American City Business Journals16 days ago

    OP company files antitrust suit against pharmacy giant

    Pharmacy First filed suit against Express Scripts after the company narrowed its network of pharmacy administrators.

  • 3 Big Stock Charts for Thursday: Express Scripts Holding Co, Alexion Pharmaceuticals and Ventas
    InvestorPlace16 days ago

    3 Big Stock Charts for Thursday: Express Scripts Holding Co, Alexion Pharmaceuticals and Ventas

    Traders looking for higher-odds trading prospects, however, will want to look at Express Scripts Holding Co (NASDAQ:ESRX), Alexion Pharmaceuticals (NASDAQ:ALXN) and Ventas (NYSE:VTR) … each of which are actually getting into a bullish groove despite Tuesday’s lull. The wave of M&A within the healthcare arena, and within the pharmaceutical distribution sliver of the market in particular, has been a blessing and a curse for Express Scripts Holding. • The monthly chart indicates that the bullish move in December not only broke above a falling resistance line that had extended back to 2015’s peak, but has put a string of higher highs and higher lows in place.

  • Drugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic
    Reuters16 days ago

    Drugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic

    In the escalating battle over U.S. prescription drug prices, major pharmaceutical companies are scrambling to limit the economic damage from a new U.S. insurer tactic that coaxes patients away from expensive drugs. The latest move by insurers - which effectively forces drug companies to pay more to assist patients with their copays - is causing a decline in real U.S. drug prices this year, and is expected to become more widely adopted in 2019. Among major drugmakers, AbbVie Inc and Amgen Inc have said the most so far about the new tactic, and more drugmakers will likely face questions about it during quarterly earnings calls in July.

  • Reuters16 days ago

    FOCUS-Drugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic

    In the escalating battle over U.S. prescription drug prices, major pharmaceutical companies are scrambling to limit the economic damage from a new U.S. insurer tactic that coaxes patients away from expensive drugs. The latest move by insurers - which effectively forces drug companies to pay more to assist patients with their copays - is causing a decline in real U.S. drug prices this year, and is expected to become more widely adopted in 2019. Among major drugmakers, AbbVie Inc and Amgen Inc have said the most so far about the new tactic, and more drugmakers will likely face questions about it during quarterly earnings calls in July.

  • CNBC18 days ago

    Amazon could start selling prescription drugs as soon as PillPack deal closes

    Amazon bought internet pharmacy start-up PillPack last week for around $1 billion. Drug supply chain experts suggest that the company could target the growing niche of people who pay out-of-pocket for their meds. Now that Amazon AMZN has snapped up internet pharmacy PillPack for around $1 billion in cash , how long will it take before consumers can rely on the e-commerce giant for their medicines, as they do for groceries, clothing, books and pretty much everything else?

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit21 days ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    This could indicate that investors who seek to profit from falling equity prices are not currently targeting ESRX. Over the last one-month, outflows of investor capital in ETFs holding ESRX totaled $2.06 billion.